Serafini Marta, Sacchetti Benedetto, Pievani Alice, Redaelli Daniela, Remoli Cristina, Biondi Andrea, Riminucci Mara, Bianco Paolo
Dulbecco Telethon Institute at Tettamanti Research Center, Pediatric Department, University of Milano - Bicocca, Monza, Italy; Tettamanti Research Center, Pediatric Department, University of Milano - Bicocca, San Gerardo Hospital, Monza, Italy.
Stem Cell Lab, Department of Molecular Medicine, Sapienza University of Rome, Italy.
Stem Cell Res. 2014 May;12(3):659-72. doi: 10.1016/j.scr.2014.01.006. Epub 2014 Feb 8.
Human bone marrow stromal cells (BMSCs, also known as bone marrow-derived "mesenchymal stem cells") can establish the hematopoietic microenvironment within heterotopic ossicles generated by transplantation at non-skeletal sites. Here we show that non-mineralized cartilage pellets formed by hBMSCs ex vivo generate complete ossicles upon heterotopic transplantation in the absence of exogenous scaffolds. These ossicles display a remarkable degree of architectural fidelity, showing that an exogenous conductive scaffold is not an absolute requirement for bone formation by transplanted BMSCs. Marrow cavities within the ossicles include erythroid, myeloid and granulopoietic lineages, clonogenic hematopoietic progenitors and phenotypic HSCs, indicating that complete stem cell niches and hematopoiesis are established. hBMSCs (CD146(+) adventitial reticular cells) are established in the heterotopic chimeric bone marrow through a unique process of endochondral bone marrow formation, distinct from physiological endochondral bone formation. In this process, chondrocytes remain viable and proliferate within the pellet, are released from cartilage, and convert into bone marrow stromal cells. Once explanted in secondary culture, these cells retain phenotype and properties of skeletal stem cells ("MSCs"), including the ability to form secondary cartilage pellets and secondary ossicles upon serial transplantation. Ex vivo, hBMSCs initially induced to form cartilage pellets can be reestablished in adherent culture and can modulate gene expression between cartilage and stromal cell phenotypes. These data show that so-called "cartilage differentiation" of BMSCs in vitro is a reversible phenomenon, which is actually reverted, in vivo, to the effect of generating stromal cells supporting the homing of hematopoietic stem cells and progenitors.
人骨髓基质细胞(BMSCs,也称为骨髓来源的“间充质干细胞”)能够在非骨骼部位移植产生的异位小骨内建立造血微环境。在此,我们表明,hBMSCs在体外形成的非矿化软骨颗粒在异位移植时,无需外源性支架即可生成完整的小骨。这些小骨呈现出显著的结构保真度,表明外源性导电支架并非移植的BMSCs形成骨的绝对必要条件。小骨内的骨髓腔包含红系、髓系和粒系谱系、克隆造血祖细胞和表型造血干细胞,表明完整的干细胞龛和造血功能得以建立。hBMSCs(CD146(+)外膜网状细胞)通过独特的软骨内骨髓形成过程在异位嵌合骨髓中得以建立,这一过程不同于生理性软骨内骨形成。在此过程中,软骨细胞在颗粒内保持存活并增殖,从软骨中释放出来,并转化为骨髓基质细胞。一旦在二次培养中移出,这些细胞保留骨骼干细胞(“MSCs”)的表型和特性,包括在连续移植时形成二次软骨颗粒和二次小骨的能力。在体外,最初诱导形成软骨颗粒的hBMSCs可在贴壁培养中重新建立,并可调节软骨和基质细胞表型之间的基因表达。这些数据表明,BMSCs在体外的所谓“软骨分化”是一种可逆现象,实际上在体内会逆转,产生支持造血干细胞和祖细胞归巢的基质细胞。